I
ILA
ISLAND PHARMA
0.375
-0.020-5.06%Closed14:18 04/02 AEDT
OPEN/PREV CLOSE0.370/0.370
TODAY RANGE0.365-0.375
VOL84.63K
MARKET CAP107.89M
52 WEEK RANGE0.120-0.630
AVG VOL (3M)469.71K
% TURNOVER0.03%
TURNOVER31.15K
P/E (TTM)-11.8893
% RANGE2.70%
EPS(TTM)-0.0307
P/E(FORWARD)-20.6215
P/B13.72
BVPS0.027
DIVIDEND--
P/S1,825.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP53.03M
SHARES OUTSTANDING295.58M
NEXT EARNINGS--
FREE FLOAT145.28M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·03/30 00:20
Cleansing Notice
ASX·03/30 00:20
Application for quotation of securities - ILA
ASX·03/22 23:31
Cleansing Notice
ASX·03/22 23:29
Application for quotation of securities - ILA
ASX·03/08 22:48
Antiviral pipeline expansion through strategic collaboration
ASX·03/03 22:23
US Government collaboration for Galidesivir development
ASX·03/01 22:39
Trading Halt
ASX·02/25 00:00
ISLAND PHARMACEUTICALS LIMITED Interim H1
ASX·02/15 21:29
Cleansing Notice
ASX·02/15 21:23
Application for quotation of securities - ILA
ASX·02/09 23:48
Response to ASX Query Letter
ASX·02/04 22:59
Investor presentation
ASX·02/03 22:35
Proposed issue of securities - ILA
ASX·02/03 22:35
$9m placement to advance US biodefence opportunity
ASX·02/03 22:31
FDA confirms Galidesivir approval pathway
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others